title: [Epsilon aminocaproic acid for management of traumatic hyphema with large blood clot in the anterior chamber].
abstract: Epsilon aminocaproic acid (EACA) is an antifibrinolytic agent currently used in the management of traumatic hyphema. It is effective in reducing the rebleed rate, but a long-standing blood clot in the anterior chamber predisposes to complications, such as corneal blood staining and elevated intraocular pressure. We assume that a large blood clot in the anterior chamber might be a contraindication to the use of EACA.
authors: Dept. of Ophthalmology, Goldschleger Eye Institute, Chaim Sheba MedicalCenter, Tel Hashomer and Sackler School of Medicine, Tel Aviv University.
authors: R
authors: R
authors: Kotas
authors: D
authors: D
authors: Neumann
authors: I
authors: I
authors: Ashkenazi
mesh_terms: D000328:Adult; D015119:Aminocaproic Acid / Q000627:therapeutic use*; D000075202:Contraindications; D005131:Eye Injuries / Q000150:complications*; D006801:Humans; D006988:Hyphema / Q000188:drug therapy*
chemical_list: D015119:Aminocaproic Acid